BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37513690)

  • 1. An Okinawan-Based Nordic Diet Leads to Profound Effects on Gut Microbiota and Plasma Metabolites Linked to Glucose and Lipid Metabolism.
    Manoharan L; Roth B; Bang C; Stenlund H; Ohlsson B
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma.
    Nilholm C; Roth B; Höglund P; Blennow K; Englund E; Hansson O; Zetterberg H; Ohlsson B
    Nutr Res; 2018 Dec; 60():13-25. PubMed ID: 30527256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes.
    Houghton D; Hardy T; Stewart C; Errington L; Day CP; Trenell MI; Avery L
    Diabetologia; 2018 Aug; 61(8):1700-1711. PubMed ID: 29754286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
    Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
    J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies.
    Letchumanan G; Abdullah N; Marlini M; Baharom N; Lawley B; Omar MR; Mohideen FBS; Addnan FH; Nur Fariha MM; Ismail Z; Pathmanathan SG
    Front Cell Infect Microbiol; 2022; 12():943427. PubMed ID: 36046745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthropometric and metabolic improvements in human type 2 diabetes after introduction of an Okinawan-based Nordic diet are not associated with changes in microbial diversity or SCFA concentrations.
    Huang F; Nilholm C; Roth B; Linninge C; Höglund P; Nyman M; Ohlsson B
    Int J Food Sci Nutr; 2018 Sep; 69(6):729-740. PubMed ID: 29199483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian Hamsters.
    Horne RG; Yu Y; Zhang R; Abdalqadir N; Rossi L; Surette M; Sherman PM; Adeli K
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233570
    [No Abstract]   [Full Text] [Related]  

  • 9. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
    Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
    United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose-Induced Intestinal Microbiota Shift Following Two Types of Short-Term High-Fructose Dietary Phases.
    Beisner J; Gonzalez-Granda A; Basrai M; Damms-Machado A; Bischoff SC
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33182700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites.
    Meng Q; Ma M; Zhang W; Bi Y; Cheng P; Yu X; Fu Y; Chao Y; Ji T; Li J; Chen Q; Zhang Q; Li Y; Shan J; Bian H
    Gut Microbes; 2021; 13(1):1-27. PubMed ID: 33691599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
    Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
    J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth investigation of the therapeutic effect of Tribulus terrestris L. on type 2 diabetes based on intestinal microbiota and feces metabolomics.
    Meng X; Shi M; Guo G; Xing J; Liu Z; Song F; Liu S
    J Ethnopharmacol; 2024 May; 325():117815. PubMed ID: 38309487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified highland barley regulates lipid metabolism, liver inflammation and gut microbiota in high-fat/cholesterol diet mice as revealed by LC-MS based metabonomics.
    Li X; Du Y; Zhang C; Tu Z; Wang L
    Food Funct; 2022 Aug; 13(17):9119-9142. PubMed ID: 35950689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of galactooligosaccharides on maternal gut microbiota, glucose metabolism, lipid metabolism and inflammation in pregnancy: A randomized controlled pilot study.
    Wan J; An L; Ren Z; Wang S; Yang H; Ma J
    Front Endocrinol (Lausanne); 2023; 14():1034266. PubMed ID: 36777355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota combined with metabolomics reveals the metabolic profile of the normal aging process and the anti-aging effect of FuFang Zhenshu TiaoZhi(FTZ) in mice.
    Luo D; Chen K; Li J; Fang Z; Pang H; Yin Y; Rong X; Guo J
    Biomed Pharmacother; 2020 Jan; 121():109550. PubMed ID: 31704617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Consuming Xylitol on Gut Microbiota and Lipid Metabolism in Mice.
    Uebanso T; Kano S; Yoshimoto A; Naito C; Shimohata T; Mawatari K; Takahashi A
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28708089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites.
    Zhang Y; Liu L; Wei C; Wang X; Li R; Xu X; Zhang Y; Geng G; Dang K; Ming Z; Tao X; Xu H; Yan X; Zhang J; Hu J; Li Y
    BMC Med; 2023 May; 21(1):174. PubMed ID: 37147641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.